Neue Regelungen für Estragol – eine Einordnung

Literatur
1 Atkinson RG. Phenylpropenes: occurrence, distribution, and biosynthesis in fruit. J Agric Food Chem 2018; 66: 2259-2272
2 Aznar M, Úbeda S, Nerin C. et al. Fabric phase sorptive extraction as a reliable tool for rapid screening and detection of freshness markers in oranges. J Chromatogr A 2017; 1500: 32-42
3 Bristol DW. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice. Toxic Rep Ser 2011; 1-111
4 EFSA (European Food Safety Authority). Protocol for the Scientific Opinion on the evaluation of the safety in use of preparations from the fruits of sweet and bitter fennel (Foeniculum vulgare Mill. and Foeniculum piperitum (Ucria) C.Presl). EFSA supporting publication 2023: EN-8245
5 EFSA. Bewertung der Sicherheit von Fencheltee bei besonders vulnerablen Verbrauchergruppen (Kinder, Schwangere, Stillende). 2023
6 EMA (European Medicines Agency). Co-ordination Group for Mutual Recognition and Decentralised Procedures (CMDh). Report from the CMDh meeting held on 22-23 February 2022 (EMA/CMDh/78976/2022), 2 March 2022
7 Europäische Kommission. Verordnung (EG) Nr. 1334/2008 des Europäischen Parlaments und des Rates vom 16. Dezember 2008 über Aromen und bestimmte Lebensmittelzutaten mit Aromaeigenschaften zur Verwendung in und auf Lebensmitteln sowie zur Änderung der Verordnung (EWG) Nr. 1601/91 des Rates, der Verordnungen (EG) Nr. 2232/96 und (EG) Nr. 110/2008 und der Richtlinie 2000/13/EG
8 Europäische Kommission. Verordnung (EU) 2023/915 der Kommission vom 25. April 2023 über Höchstgehalte für bestimmte Kontaminanten in Lebensmitteln und zur Aufhebung der Verordnung (EG) Nr. 1881/2006
9 HMPC der EMA. Assessment report on Foeniculum vulgare Miller. Doc. Ref. EMEA/HMPC/137426/2006
10 HMPC der EMA. Community herbal monograph on Foeniculum vulgare. 2007; Doc. Ref. EMEA/HMPC/137428/2006 Corr
11 HMPC der EMA. Public statement on the use of herbal medicinal products containing estragole. EMA/HMPC/137212/2005 Rev 1 Corr 1. 2023
12 HMPC der EMA. Public statement on the use of herbal medicinal products containing estragole. EMA/HMPC/137212/2005. 2005
13 ICH guideline M7(R1) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk - Step 5 (EMA/CHMP/ICH/83812/2013) European Medicines Agency, Committee for Human Medicinal Products, 25 August 2015
14 Kalleli F, Bettaieb Rebey I, Wannes WA. et al. Chemical composition and antioxidant potential of essential oil and methanol extract from Tunisian and French fennel (Foeniculum vulgare Mill.) seeds. J Food Biochem 2019; 43: e12935
15 Kaufmann WK, MacKenzie SA, Kaufman DG. Quantitative relationship between hepatocytic neoplasms and islands of cellular alteration during hepatocarcinogenesis in the male F344 rat. Am J Pathol 1985; 119: 171-174
16 Kunz HW, Tennekes HA, Port RE. et al. Quantitative aspects of chemical carcinogenesis and tumor promotion in liver. Environ Health Perspect 1983; 50: 113-122
17 Marsman DS, Popp JA. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis 1994; 15: 111-117
18 Mihats D, Pilsbacher L, Gabernig R. et al. Levels of estragole in fennel teas marketed in Austria and assessment of dietary exposure. Int J Food Sci Nutr 2017; 68: 569-576
19 Miller EC, Swanson AB, Phillips DH. et al. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res 1983; 43: 1124-1134
20 Morales MR, Charles DJ, Simon JE. New aromatic lemon basil germplasm. In: Janick J, Simon JE, eds. New crops. New York: Wiley; 1993: 632-635
21 Muráriková A, Tazký A, Neugebauerová J. et al. Characterization of essential oil composition in different basil species and pot cultures by a GC-MS method. Molecules 2017; 22: 1221
22 Obolskiy D, Pischel I, Feistel B. et al. Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety. J Agric Food Chem 2011; 59: 11367-11384
23 Rapisarda V, Loreto C, Malaguarnera M. et al. Hepatocellular carcinoma and the risk of occupational exposure. World J Hepatol 2016; 8: 573-590
24 Robert Koch-Institut, Zentrum für Krebsregisterdaten (ZfKD). Bericht „Cancer in Germany 2019/2020“. 14th edition. Robert Koch Institute (ed.) and the Association of Population-based Cancer Registries in Germany (ed.). Berlin, 2024
25 Schulte-Hubbert R, Küpper JH, Thomas AD, Schrenk D. Estragole: DNA adduct formation in primary rat hepatocytes and genotoxic potential in HepG2-CYP1A2 cells. Toxicology.. 2020. 444. 152566
26 Statistisches Bundesamt (Destatis) https://www.destatis.de abgerufen am 09.08.2024
27 Yang S, Wesseling S, Rietjens IM. Estragole DNA adduct accumulation in human liver HepaRG cells upon repeated in vitro exposure. Toxicol Lett 2021; 337: 1-6